(KMB) Kimberly-Clark - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4943681035
KMB: Diapers, Tissues, Towels, Wipes, Napkins, Sanitizers
KMB, Kimberly-Clark Corporation, is a household name in the consumer staples sector, with a history dating back to 1872. The company operates in three core segments: Personal Care, Consumer Tissue, and K-C Professional. Its Personal Care division dominates the market for disposable diapers, wipes, and feminine care products under iconic brands like Huggies, Kotex, and Poise. This segment is a cash cow, given the recurring nature of these products.
The Consumer Tissue segment is equally impressive, with Kleenex and Scott being staples in many households. Their product range includes facial tissues, paper towels, and napkins. The K-C Professional segment caters to the B2B market, offering everything from industrial wipes to personal protective equipment. This diversification across both consumer and professional markets provides stability and reduces reliance on any single revenue stream.
From a financial standpoint, KMB boasts a market cap of over $43 billion, with a P/E ratio of 17.27 and a forward P/E of 17.18, indicating a fairly valued stock. The P/S ratio of 2.17 reflects a premium for their strong brand portfolio. KMB is known for its consistent dividend payouts, making it a favorite among income investors. The companys global presence, with operations in over 150 countries, adds to its appeal, as does its commitment to innovation and sustainability, which positions it well for long-term growth in the evolving consumer landscape.
Additional Sources for KMB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
KMB Stock Overview
Market Cap in USD | 44,005m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1984-12-17 |
KMB Stock Ratings
Growth 5y | 27.1% |
Fundamental | 33.8% |
Dividend | 46.3% |
Rel. Strength Industry | 6.18 |
Analysts | 3.3/5 |
Fair Price Momentum | 136.20 USD |
Fair Price DCF | 175.07 USD |
KMB Dividends
Dividend Yield 12m | 3.57% |
Yield on Cost 5y | 4.14% |
Annual Growth 5y | 2.66% |
Payout Consistency | 41.4% |
KMB Growth Ratios
Growth Correlation 3m | -32.2% |
Growth Correlation 12m | 30.1% |
Growth Correlation 5y | 44.2% |
CAGR 5y | 3.52% |
CAGR/Max DD 5y | 0.14 |
Sharpe Ratio 12m | 0.88 |
Alpha | 13.57 |
Beta | 0.14 |
Volatility | 23.56% |
Current Volume | 2316.6k |
Average Volume 20d | 2324.4k |
As of February 22, 2025, the stock is trading at USD 140.26 with a total of 2,316,600 shares traded.
Over the past week, the price has changed by +5.72%, over one month by +10.86%, over three months by +3.27% and over the past year by +20.70%.
Neither. Based on ValueRay Fundamental Analyses, Kimberly-Clark is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 33.81 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KMB as of February 2025 is 136.20. This means that KMB is currently overvalued and has a potential downside of -2.89%.
Kimberly-Clark has received a consensus analysts rating of 3.30. Therefor, it is recommend to hold KMB.
- Strong Buy: 3
- Buy: 3
- Hold: 12
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, KMB Kimberly-Clark will be worth about 148.4 in February 2026. The stock is currently trading at 140.26. This means that the stock has a potential upside of +5.78%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 143.8 | 2.6% |
Analysts Target Price | 147.8 | 5.4% |
ValueRay Target Price | 148.4 | 5.8% |